Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake

The article " Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake " first appeared on MarketBeat.

Pfizer: Why Wall Street Gave Up—And Why That May Be a Mistake

Pfizer enters the new year as a company in transition, but one with a heavily fortified bottom line. Management has set a revenue floor of approximately $61 billion for 2026. This is a realistic, ...

Want plump, wrinkle-free skin in 2026 without Botox or fillers? The 5 skincare resolutions you need to make

BEFORE the clock strikes 12 on New Year’s Eve, you need to have nailed down your 2026 beauty resolutions. Whilst some ...
Tampa Free Press on MSN

Ditch the needle: FDA greenlights first daily pill version of Wegovy

For the millions of Americans navigating the booming landscape of weight loss medications, the weekly injection routine just got a potential alternative. The FDA has officially approved a daily pill ...
Healthline

Leqvio for High Cholesterol

Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
National Institute for Health and Care Excellence

Library and knowledge resources

We provide access to a range of journals, databases and other evidence-based resources for health and social care staff in England. You'll need an NHS OpenAthens account to access most of these ...